Bis[di-tert-butyl(4-dimethylaminophenyl)phosphine]palladium(0)>98.0%(T)500mg

[3-(3-pyridin-4-yl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)phenyl]amine, 95.0%, 500mg

3,5,6-Trichloro-1,2,4-triazine, 95.0%, 100g

5-Norbornen-2-yl Acetate (endo- and exo- mixture)>96.0%(GC)25g

(S)-2,2'-((5-Amino-1-carboxypentyl)azanediyl)diacetic acid, 95.0%, 100g

Methyl 5-bromoquinoline-8-carboxylate, 95.0%, 1g

4-(3-Fluoro-4-methylphenyl)-4-oxobutyric acid, 97.0%, 1g

Sodium hydroxide solution, ROTIPURAN® min. 32%, pa, 5 l, plastic packaging.

9-((tert-Butoxycarbonyl)amino)nonanoic acid, 95.0%, 250mg

Kinetin, 95.0%, 5g

7-(prop-2-yn-1-yl)-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]thiazol-6(7H)-imine hydrobromide, 95.0%, 500mg

2-(3-((3-Methoxybenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 1g

1-Chloronaphthalene, 85.0%, 25g